JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandle, R.
Right arrow Articles by Kaplan, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandle, R., Jr
Right arrow Articles by Kaplan, A. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

JBC, Vol. 252, Issue 17, 6097-6104, Sep, 1977

Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis

R. Mandle Jr and A. P. Kaplan

Two molecular forms of prekallikrein can be isolated from pooled normal human plasma. Their approximate molecular weights by sodium dodecyl sulfate-gel electrophoresis are 88,000 and 85,000. The two bands observed are shown to represent prekallikrein by functional, immunochemical, and structural criteria. Both forms are cleaved by activated Hageman factor, they appear to share antigenic determinants, they are not interconvertible upon incubation with activated Hageman factor or kallikrein, and the ratio of kinin-generating, and plasminogen-activating activities of the preparations are independent of the relative proportion of each band. Activated Factor XII converts prekallikrein to kallikrein by limited proteolysis and two disulfide-linked chains designated kallikrein heavy chain (Mr = 52,000) and kallikrein light chains (Mr = 36,000 or 33,000) are formed. The active site is associated with the light chains as assessed by incorporation of [3H]diisopropyl fluorophosphate. No dissociable fragments were observed in the absence of reducing agents. However, kallikrein could digest prekallikrein to diminish its molecular weight by 10,000. In addition, two factors capable of activating plasminogen to plasmin have been isolated; one is identified as kallikrein. The second principle fractionates with Factor XI and is demonstrable in normal and prekallikrein-deficient plasma.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. H. Schmaier
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R1 - R13.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
, , S. , M. , J. , S. , G. , and G. J. Miller
Epidemiological and Genetic Associations of Activated Factor XII Concentration With Factor VII Activity, Fibrinopeptide A Concentration, and Risk of Coronary Heart Disease in
Circulation, October 24, 2000; 102(17): 2058 - 2062.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Motta, R. Rojkjaer, A. A.K. Hasan, D. B. Cines, and A. H. Schmaier
High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation
Blood, January 15, 1998; 91(2): 516 - 528.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. W. Colman and A. H. Schmaier
Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes
Blood, November 15, 1997; 90(10): 3819 - 3843.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G.J. Miller, M.P. Esnouf, A.I. Burgess, J.A. Cooper, and J.P. Mitchell
Risk of Coronary Heart Disease and Activation of Factor XII in Middle-Aged Men
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2103 - 2106.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Herwald, T. Renne, J. C. M. Meijers, D. W. Chung, J. D. Page, R. W. Colman, and W. Muller-Esterl
Mapping of the Discontinuous Kininogen Binding Site of Prekallikrein. A DISTAL BINDING SEGMENT IS LOCATED IN THE HEAVY CHAIN DOMAIN A4
J. Biol. Chem., May 31, 1996; 271(22): 13061 - 13067.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
J. M Courtney, B. M Matata, H. Q Yin, A. Esposito, A. Mahiout, D. P Taggart, and G. Lowe
The influence of biomaterials on inflammatory responses to cardiopulmonary bypass
Perfusion, May 1, 1996; 11(3): 220 - 228.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1977 by the American Society for Biochemistry and Molecular Biology.